Conquer Cancer Foundation Honors 65 Young Oncology Professionals with Merit Awards

Mar 07, 2017

The Conquer Cancer Foundation of ASCO (CCF) is pleased to announce the recipients of its 2017 CCF Merit Awards in Gastrointestinal Cancer, Cancer Survivorship, Genitourinary Cancer, Immuno-Oncology, and Quality Care. The following 65 young researchers, recognized for the scientific merit of their abstracts and their valuable contributions to their areas of study, accepted their awards and presented their research findings at recent thematic symposia.

2017 Conquer Cancer Foundation of ASCO Merit Awards in Gastrointestinal Cancers

Twenty-five Merit Award recipients were recognized at the 2017 Gastrointestinal Cancers Symposium, which took place January 19-21 in San Francisco, California. The recipients and their abstracts are:

The 2017 Conquer Cancer Foundation of ASCO Merit Awards in Gastrointestinal Cancers are supported by Amgen, AstraZeneca, Ipsen Biopharmaceuticals Inc., Janssen Oncology, Kidney Cancer Association, Lilly, Merck & Co., Inc., Novartis Oncology, and Takeda Oncology.

2017 Conquer Cancer Foundation of ASCO Merit Awards in Cancer Survivorship

Five Merit Award recipients were recognized at the 2017 Cancer Survivorship Symposium, which took place January 27-28 in San Diego, California. The recipients and their abstract include:

The 2017 Conquer Cancer Foundation of ASCO Merit Awards in Cancer Survivorship are supported by Amgen, AstraZeneca, Ipsen Biopharmaceuticals Inc., Janssen Oncology, Kidney Cancer Association, Lilly, Merck & Co., Inc., Novartis Oncology, and Takeda Oncology.

2017 Conquer Cancer Foundation of ASCO Merit Awards in Genitourinary Cancers

Twenty Merit Award recipients were recognized at the 2017 Genitourinary Cancers Symposium, which took place February 16-18 in Orlando, Florida. The recipients and their abstracts are:

The 2017 Conquer Cancer Foundation of ASCO Merit Awards in Genitourinary Cancers are supported by Amgen, AstraZeneca, Ipsen Biopharmaceuticals Inc., Janssen Oncology, Kidney Cancer Association, Lilly, Merck & Co., Inc., Novartis Oncology, and Takeda Oncology.

2017 Conquer Cancer Foundation of ASCO Merit Awards in Immuno-Oncology

Five Merit Award recipients were recognized at the 2017 ASCO-SITC Clinical Immuno-Oncology Symposium, which took place February 23-25 in Orlando, Florida. The recipients and their abstracts are:

The 2017 Conquer Cancer Foundation of ASCO Merit Awards in Immuno-Oncology are supported by Amgen, AstraZeneca, Ipsen Biopharmaceuticals Inc., Janssen Oncology, Kidney Cancer Association, Lilly, Merck & Co., Inc., Novartis Oncology, and Takeda Oncology.

2017 Conquer Cancer Foundation of ASCO Merit Awards in Quality Care

Ten Merit Award recipients were recognized at the 2017 Quality Care Symposium, which took place March 3-4 in Orlando, Florida. The recipients and their abstracts are:

The 2017 Conquer Cancer Foundation of ASCO Merit Awards in Quality Care are supported by Amgen, AstraZeneca, Ipsen Biopharmaceuticals Inc., Janssen Oncology, Kidney Cancer Association, Lilly, Merck & Co., Inc., Novartis Oncology, and Takeda Oncology.

Back to Top